TickerFactsScreenerDevelopers

AIM ImmunoTech Inc. (AIM) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2009: $332.0K2010: $729.0K2011: $1.80M2012: $5.75M2013: $898.0K2014: $504.0K2015: $240.0K2016: $160.0K2017: $20.0K2018: $51.0K2019: $68.0K2020: $22.0K2021: $41.0K2022: $86.0K2024: $18.0K$18.0K
2009Capital Expenditures (USD)2024
Fiscal YearCapital ExpendituresChange YoY
2024$18.0K—
2022$86.0K+109.8%
2021$41.0K+86.4%
2020$22.0K-67.6%
2019$68.0K+33.3%
2018$51.0K+155.0%
2017$20.0K-87.5%
2016$160.0K-33.3%
2015$240.0K-52.4%
2014$504.0K-43.9%
2013$898.0K-84.4%
2012$5.75M+219.4%
2011$1.80M+147.2%
2010$729.0K+119.6%
2009$332.0K—